M&G plc’s Regeneron Pharmaceuticals REGN Stock Holding History

M&G plc’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,026	Closed	-$7.88M	–	413
2025 Q3	$7.88M	Buy	14,026 +451	+3%	+$255K	0.04%	236
2025 Q2	$7.13M	Buy	13,575 +2	+0%	+$1.12K	0.04%	251
2025 Q1	$8.61M	Buy	13,573 +820	+6%	+$564K	0.04%	229
2024 Q4	$9.08M	Buy	+12,753	New	+$10.7M	0.06%	234

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

M&G plc's REGN Position: Q4 2025 in Review

M&G plc sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 14,026 shares — an estimated $7.88M sold.

M&G plc first reported a position in REGN in Q4 2024 and held it in 4 quarters. The position peaked at $9.08M in Q4 2024. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

M&G plc reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
M&G plc sold 14,026 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $7.88M.
M&G plc first reported a position in Regeneron Pharmaceuticals in Q4 2024 and held it in 4 quarters.
M&G plc's Regeneron Pharmaceuticals position peaked at $9.08M in Q4 2024.
1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on M&G plc's 13F filing for Q4 2025, filed 12 Feb 2026.